+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Comparative effect of statins on the risk of incident Alzheimer disease



Comparative effect of statins on the risk of incident Alzheimer disease



Neurology 90(3): E179-E187



To investigate whether fungus-derived statins are associated with a lower risk of incident Alzheimer disease (AD) compared with synthetic statins using real-world clinical practice data. We identified a population-based retrospective cohort of patients aged ≥60 years newly prescribed a statin between January 1, 1994, and December 31, 2012, and followed until March 31, 2015, using the UK Clinical Practice Research Datalink. Statins were consecutively classified according to their type, lipophilicity, and potency. For each group, we calculated the crude AD incidence rates per 1,000 person-years. Time-dependent Cox proportional hazards models adjusted for propensity score deciles were used to estimate hazard ratios (HRs) with 95% confidence interval (CIs) of incident AD associated with different statin categories. Over the 18-year study period, we identified 465,085 statin users, including 7,669 patients who developed AD during 2,891,268 person-years of follow-up (incidence rate 2.65 [95% CI 2.59-2.71] per 1,000 person-years). Compared to synthetic, fungus-derived statins were associated with an increased risk of AD (HR 1.09, 95% CI 1.03-1.15). Lipophilic statins also were associated with higher AD risk (HR 1.18, 95% CI 1.09-1.27) compared to hydrophilic statins, while statin potency did not modify the risk of AD (adjusted HR 1.03, 95% CI 0.98-1.08). The risk was further reduced in sensitivity analyses. Fungus-derived and lipophilic statins were not associated with decreased incidence of AD compared to synthetic and hydrophilic statins. The modest variations in the risk of incident AD observed between statin characteristics needs to be evaluated in future studies on their possible heterogeneous neuroprotective effect.

(PDF emailed within 0-6 h: $19.90)

Accession: 055499000

Download citation: RISBibTeXText

PMID: 29247073

DOI: 10.1212/WNL.0000000000004818


Related references

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Archives of General Psychiatry 62(2): 217-224, 2005

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 71(24): 2020; Author Reply 2020-1, 2009

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 71(24): 2019; Author Reply 2019-20, 2008

Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study. Journal of Affective Disorders 238: 542-546, 2018

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease. Neurobiology of Aging 36(1): 60-67, 2015

Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Archives of General Psychiatry 67(3): 304-310, 2010

Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study. American Journal of Clinical Nutrition 105(2): 476-484, 2017

Statins may reduce risk of Alzheimer's disease. Bmj 321(7268): 1040, 2000

Statins for the reduction of risk of Alzheimer's disease. Cochrane Database of Systematic Reviews 2001(3): Cd003160, 2001

Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65(4): 545-551, 2005

Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review. Asian Journal of Andrology 19(6): 666-671, 2016

Grip strength and the risk of incident Alzheimer's disease. Neuroepidemiology 29(1-2): 66-73, 2007

Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology 60(2): 194-200, 2003

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. Journal of Neurology, Neurosurgery, and Psychiatry 80(1): 13-17, 2008

MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 64(9): 1520-1524, 2005